Device
ExAblate Transcranial System
ExAblate Transcranial System is a medical device with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
active_not_recruiting240%
completed360%
Recent Activity
2 active trials
Showing 5 of 5
completednot_applicable
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
NCT02246374
active_not_recruitingnot_applicable
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NCT00147056
active_not_recruitingnot_applicable
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors
NCT01473485
completednot_applicable
ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease
NCT02263885
completednot_applicable
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor
NCT01932463
Clinical Trials (5)
Showing 5 of 5 trials
NCT02246374Not Applicable
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
NCT00147056Not Applicable
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NCT01473485Not Applicable
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors
NCT02263885Not Applicable
ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease
NCT01932463Not Applicable
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5